| The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making
|
| Author(s): Paul Cottu 1, Scott David Ramsey 2, Oriol Solà-Morales 3, Patricia A Spears 4, Lockwood Taylor 5 |
| Affiliations(s): 1Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005, Paris, France. Electronic address: paul.cottu@curie.fr.
2Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B232, Seattle, WA, 98155, USA. Electronic address: sramsey@fredhutch.org.
3Health Innovation Technology Transfer Foundation, Aragó 60, E-08015, Barcelona, Spain. Electronic address: osola@fhitt.org.
48605 Carolingian Court, Raleigh, NC, 27615, USA. Electronic address: paspears88@gmail.com.
5Epidemiology, Real World Solutions at IQVIA, 4820 Emperor Boulevard, Durham, NC, 27703, USA. Electronic address: lockwood.taylor@iqvia.com. |
Publication(s): Breast. 2021 Dec 22;61:118-122. doi: 10.1016/j.breast.2021.12.015.
|
| Document Type(s): Article, |
| Countries: France, Italy, USA, |
| Click here for the abstract |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment, Drug safety, Oncology, Regulatory,
2022 |
|
L:
A: |
English
Review, |
|
 |
| |
| |
| POSB392 Understanding the Secondary Care Characteristics and Pathways of Multiple Myeloma Patients Who Reach Second-Line Therapy Using the Hospital Episode Statistics (HES) Database
|
| Author(s): E Mary Babu
S Fermahan
S Chavda
M Chetty
S Navani
A Matthew
R Hudson |
| Affiliations(s): Sanofi, Reading, RDG, UK
IQVIA, London, UK |
Publication(s): Mary Babu, E et al.
Value in Health, Volume 25, Issue 1, S257
|
| Document Type(s): Abstract, Article, |
| Countries: England, |
| Click here for the abstract |
C:
Y: |
Oncology,
2022 |
|
L:
A: |
English
Burden of illness, clinical setting: Secondary care, Database Study, Population Based Study, Retrospective database analysis, |
|
|
| |
| |
| Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan |
| Author(s): Masaki Shiota 1,Raf De Moor 2,Yosuke Koroki 2,Dae Young Yu 3,David Bin-Chia Wu 4 |
| Affiliations(s): 1) Department of Urology, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Japan
2) Integrated Market Access, Janssen Pharmaceutical KK, Tokyo, Japan
3) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore
4) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore;e Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore;f School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia |
Publication(s): Current Medical Research and Opinion
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Oncology,
2022 |
|
L:
A: |
English
Database Study, |
|
|
| |
| |
| Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study
|
| Author(s): Arena PJ, Huang K, Löfling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, Sundbøll J, Rasmussen TR, Løkke A, Ehrenstein V.
|
| Affiliations(s): "Pfizer Inc., New York, New York, United States of America.
Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America.
EPID Research (an IQVIA company), Espoo, Finland."
|
Publication(s): Pharmacoepidemiol Drug Saf. 2022 Dec 10. doi: 10.1002/pds.5582
|
| Document Type(s): Article, |
| Countries: Denmark, Finland, Netherlands , Sweden, USA, |
| Click here for the abstract |
C:
Y: |
Database Validity and methodology, Drug safety, Oncology,
2022 |
|
L:
A: |
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis, |
|
|
| |
| |
| High?Expenditure Disease in the EU?28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes? |
| Author(s): Wolfgang Greiner, Keyur Patel, Christina-Jane Crossman-Barnes, Troels Vingtoft Rye-Andersen, Christian Hvid, Tom Vandebrouck |
| Affiliations(s): Department for Health Economics, Bielefeld University, Bielefeld, Germany; IQVIA Ltd, HEOR, London, UK; Novo Nordisk Region Europe Pharmaceuticals A/S, Copenhagen, Denmark; Novo Nordisk Region Europe Pharmaceuticals A/S, Brussels, Belgium |
Publication(s): PharmacoEconomics-Open. 2021 Jan; doi.org/10.1007/s41669-020-00253-4
|
| Document Type(s): Article, |
| Countries: Europe, |
| Click here for the abstract |
C:
Y: |
Diabetes, Health economics, Oncology,
2021 |
|
L:
A: |
English
Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Quality of life, Retrospective database analysis, Review, |
|
|
| |
| |
| Analisi di impatto sul budget sanitario italiano di gilteritinib per il trattamento della leucemia mieloide acuta FLT3+ recidivante o refrattaria
|
| Author(s): Fiorentino F, La Malfa P, Di Rienzo P
|
| Affiliations(s): Fiorentino F: IQVIA Solutions Italy Srl, RWS
|
Publication(s): GIHTAD (2021) 14:4
|
| Document Type(s): Article, |
| Countries: Italy, |
| Click here for the abstract |
C:
Y: |
Health economics, Oncology,
2021 |
|
L:
A: |
Italian
Budget impact, clinical setting: Secondary care, |
|
|
| |
| |
| Real-World Profiling of Non-Small Cell Lung Cancer Patients in Japan |
| Author(s): Elaine Chang Takahashi 1, Shiho Wakase 2, Masayuki Ito 1, Todd D Taylor 3 (rwesheorj 3) |
| Affiliations(s): 1) Novartis Pharma K.K., Minato-ku, Japan
2) Novartis Pharma K.K., Tokyo, Japan
3) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan |
Publication(s): ISPOR Europe 2021
|
| Document Type(s): Poster, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Oncology,
2021 |
|
L:
A: |
English
Database Study, Real World Evidence, |
|
|
| |
| |
| Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan |
| Author(s): Taro Iguchi 1, Yusuke Nakamura 2, Takeshi Akiyama 3, Krishant Chand 3, Eric Yu 3 (rwesheorj 3) |
| Affiliations(s): 1) Department of Urology, Kanazawa Medical University
2) Market and Regional Access, Bayer Yakuhin, Ltd
3) Real World Evidence Solutions, IQVIA Solutions Japan K.K. |
Publication(s): Current Medical Research and Opinion
|
| Document Type(s): Online article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Oncology,
2021 |
|
L:
A: |
English
Burden of illness, Observational study, Patient questionnaire, Population Based Study, Real World Evidence, Survey research, |
|
|
| |
| |
| Modernizing Oncology Approvals |
| Author(s): Christina Mack
|
| Affiliations(s): CAEG
|
Publication(s): PharmaVoice. 2021 Mar
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Oncology,
2021 |
|
L:
A: |
English
clinical setting: Secondary care, |
|
|
| |
| |
| Modernizing Regulatory Evidence with Trials and Real-World Studies
|
| Author(s): Nancy A. Dreyer PhD, MPH, FISPE, Marni Hall PhD, MPH & Jennifer B. Christian PharmD, MPH, PhD, FISPE |
| Affiliations(s): IQVIA Real World Solutions, 201 Broadway, 5th Floor, Cambridge, MA, 02139, USA
Nancy A. Dreyer PhD, MPH, FISPE
IQVIA Real-World Solutions, Rockville, MD, USA
Marni Hall PhD, MPH
IQVIA Real World Solutions, Research Triangle Park, NC, USA
Jennifer B. Christian PharmD, MPH, PhD, FISPE |
Publication(s): Ther Innov Regul Sci (2020). https://doi.org/10.1007/s43441-020-00131-5
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Oncology,
2020 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
 1 of 59 
|
